Although the interest in CCL2-CCR2 signaling was increased in recent years, mostly due to its relation to solid and metastatic cancers, CCR2 chemokine was not analyzed in AMD patients despite mediating not only a pro-tumorigenic function but also angiogenesis [53]. Here, CCR2 is linked to age-related macular degeneration.